News
The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback